this post was submitted on 31 Jan 2024
1 points (100.0% liked)
/r/Denmark
153 readers
1 users here now
GÅ TIL FEDDIT.DK
Kommentarerne du skriver her sendes ikke tilbage til Reddit.
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Thehunterforce at 2024-01-31 08:47:54+00:00 ID:
ko9agmj
Lad os nu ikke prøve at flytte fokus fra, at wegovy er deres hovedmotor i deres væksteventyr, som vi nu skal hylde i denne tråd.
Sales within Diabetes and Obesity care increased by 38% in Danish kroner to DKK 215.1 billion (42% at CER), mainly driven by GLP-1 diabetes sales growth of 48% in Danish kroner (52% at CER) and Obesity care growing by 147% in Danish Kroner to DKK 41.6 billion (154% at CER). Rare disease sales decreased by 16% measured in Danish kroner (15% at CER) reflecting a reduction in manufacturing output.
Wegovy og ozempic er deres GLP-1 medicin der driver denne vækst.